Page 10 - Breakthrough Device Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Financial Institutions, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call Financial Institutions, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call WARSAW, N.Y., Jan. 06, 2021 — Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), the parent company of Five Star Bank, SDN Insurance Agency, LLC (“SDN”), Courier Capital, LLC (“Courier Capital”) and HNP Capital, LLC (“HNP Capital”), will release results for the fourth quarter and full year ended December 31, 2020, after the market closes on January 2...

Kofax Announces ReadSoft Online Integration with Microsoft Dynamics 365 for Invoice & Accounts Payable Automation Kofax Announces ReadSoft Online Integration with Microsoft Dynamics 365 for Invoice & Accounts Payable Automation Kofax, a leading supplier of intelligent automation software for digital workflow transformation, today announces the integration of ReadSoft Online, its software-as-a-service (SaaS) solution for invoice data extraction and accounts payable automation, with the Microsoft Dynamics 365 platform. The integrated solutions allow organizations to transform their procure-to-p...

18 dicembre 2020 06:30 Fonte: Adnkronos #salute-e-benessere TAMPA, Fla., Dec. 17, 2020 /PRNewswire/ -- Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment of small coronary artery lesions in Coronary Artery Disease (CAD). The proposed indication for use includes "The MagicTouch SCB Sirolimus Coated Balloon Catheter is indicated for percutaneous transluminal coronary angioplasty, after appropri...

(1) TAMPA, Fla., Dec. 17, 2020 /PRNewswire/ -- Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment of small coronary artery lesions in Coronary Artery Disease (CAD). The proposed indication for use includes "The MagicTouch SCB Sirolimus Coated Balloon Catheter is indicated for percutaneous transluminal coronary angioplasty, after appropriate vessel preparation, of small coronary artery lesion ...